These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 18698414)

  • 21. Specific expression network analysis of diabetic nephropathy kidney tissue revealed key methylated sites.
    Wang YZ; Xu WW; Zhu DY; Zhang N; Wang YL; Ding M; Xie XM; Sun LL; Wang XX
    J Cell Physiol; 2018 Oct; 233(10):7139-7147. PubMed ID: 29737531
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioinformatic analysis of specific genes in diabetic nephropathy.
    Fu F; Wei X; Liu J; Mi N
    Ren Fail; 2015 Aug; 37(7):1219-24. PubMed ID: 26156684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vascular endothelial growth factor insertion/deletion gene polymorphism in West Indian patients of type 2 diabetes and diabetic nephropathy.
    Dabhi B; Mistry KN; Patel H; Lal S
    Indian J Biochem Biophys; 2015 Apr; 52(2):209-12. PubMed ID: 26118134
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gene expression in diabetic nephropathy.
    Hohenadel D; van der Woude FJ
    Curr Diab Rep; 2004 Dec; 4(6):462-9. PubMed ID: 15539012
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Redefinition of Affymetrix probe sets by sequence overlap with cDNA microarray probes reduces cross-platform inconsistencies in cancer-associated gene expression measurements.
    Carter SL; Eklund AC; Mecham BH; Kohane IS; Szallasi Z
    BMC Bioinformatics; 2005 Apr; 6():107. PubMed ID: 15850491
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specific down-regulation of connective tissue growth factor attenuates progression of nephropathy in mouse models of type 1 and type 2 diabetes.
    Guha M; Xu ZG; Tung D; Lanting L; Natarajan R
    FASEB J; 2007 Oct; 21(12):3355-68. PubMed ID: 17554073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Study the Association of Tumor Necrosis Factor Promoter Polymorphism with Type 2 Diabetic Nephropathy.
    Emara M; El-Edel R; Fathy WM; Aboelkhair NT; Watany MM; Abou-Elela DH
    Mediators Inflamm; 2020; 2020():1498278. PubMed ID: 32684830
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of novel targets of diabetic nephropathy and PEDF peptide treatment using RNA-seq.
    Rubin A; Salzberg AC; Imamura Y; Grivitishvilli A; Tombran-Tink J
    BMC Genomics; 2016 Nov; 17(1):936. PubMed ID: 27855634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome-wide pathway analysis for diabetic nephropathy in type 1 diabetes.
    Lee YH; Song GG
    Endocr Res; 2016; 41(1):21-7. PubMed ID: 26167956
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Locus and gene-based GWAS meta-analysis identifies new diabetic nephropathy genes.
    Saeed M
    Immunogenetics; 2018 Jun; 70(6):347-353. PubMed ID: 29147756
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A bioinformatics and network pharmacology approach to the mechanisms of action of Shenxiao decoction for the treatment of diabetic nephropathy.
    Mou X; Zhou DY; Zhou D; Liu K; Chen LJ; Liu WH
    Phytomedicine; 2020 Apr; 69():153192. PubMed ID: 32200292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic variations in key inflammatory cytokines exacerbates the risk of diabetic nephropathy by influencing the gene expression.
    Hameed I; Masoodi SR; Malik PA; Mir SA; Ghazanfar K; Ganai BA
    Gene; 2018 Jun; 661():51-59. PubMed ID: 29605608
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Chemerin and Vascular Endothelial Growth Factor (VEGF) with Diabetic Nephropathy.
    Lin S; Teng J; Li J; Sun F; Yuan D; Chang J
    Med Sci Monit; 2016 Sep; 22():3209-14. PubMed ID: 27612613
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sex genes for genomic analysis in human brain: internal controls for comparison of probe level data extraction.
    Galfalvy HC; Erraji-Benchekroun L; Smyrniotopoulos P; Pavlidis P; Ellis SP; Mann JJ; Sibille E; Arango V
    BMC Bioinformatics; 2003 Sep; 4():37. PubMed ID: 12962547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Key Genes Involved in Diabetic Nephropathy Investigated by Microarray Analysis.
    Liu X; Li X
    J Comput Biol; 2019 Dec; 26(12):1438-1447. PubMed ID: 31356112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of the outcome of preoperative chemotherapy in breast cancer using DNA probes that provide information on both complete and incomplete responses.
    Natowicz R; Incitti R; Horta EG; Charles B; Guinot P; Yan K; Coutant C; Andre F; Pusztai L; Rouzier R
    BMC Bioinformatics; 2008 Mar; 9():149. PubMed ID: 18366635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Positioning of Tacrolimus for the Treatment of Diabetic Nephropathy Based on Computational Network Analysis.
    Aschauer C; Perco P; Heinzel A; Sunzenauer J; Oberbauer R
    PLoS One; 2017; 12(1):e0169518. PubMed ID: 28060893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel insights into the disease transcriptome of human diabetic glomeruli and tubulointerstitium.
    Levin A; Reznichenko A; Witasp A; Liu P; Greasley PJ; Sorrentino A; Blondal T; Zambrano S; Nordström J; Bruchfeld A; Barany P; Ebefors K; Erlandsson F; Patrakka J; Stenvinkel P; Nyström J; Wernerson A
    Nephrol Dial Transplant; 2020 Dec; 35(12):2059-2072. PubMed ID: 32853351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. TNF-α-308G/A polymorphism associated with TNF-α protein expression in patients with diabetic nephropathy.
    Peng Y; Li LJ
    Int J Clin Exp Pathol; 2015; 8(3):3127-31. PubMed ID: 26045828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of biological targets of therapeutic intervention for diabetic nephropathy with bioinformatics approach.
    Wu T; Li Q; Wu T; Liu HY
    Exp Clin Endocrinol Diabetes; 2014 Nov; 122(10):587-91. PubMed ID: 25003364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.